ADVERTISEMENT

Whitenicious entrepreneur plans to sue actress Lisa Raye

Dencia plans to sue US actress Lisa Raye after she said Whitenicious causes cancer.

 

Dencia, the boss of the infamous skin lightening Whitenicious cream has threatened to sue Hollywood actress Lisa Raye for her comments she made about her product.

During her press rounds for her latest movie starring Van Vicker, Lisa Raye claimed that Whitenicious causes cancer.

Dencia heard this and ranted on Twitter threatening to sue Lisa Raye.

You can read her tweets below;

ADVERTISEMENT

Last December, Dencia claimed that she made $20m from Whitenicious. See more on Dencia below.

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.
ADVERTISEMENT

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.ng

Recommended articles

See BTS photos from  Basketmouth's upcoming film 'A Ghetto Love Story'

See BTS photos from Basketmouth's upcoming film 'A Ghetto Love Story'

Toyin Abraham to release a new 'Alakada' film in December

Toyin Abraham to release a new 'Alakada' film in December

Bella Shmurda explores the pain of loss on 'R2 Sept 12' EP [Review]

Bella Shmurda explores the pain of loss on 'R2 Sept 12' EP [Review]

Why and when British royals Meghan and Harry are visiting Nigeria

Why and when British royals Meghan and Harry are visiting Nigeria

Sola Sobowale opens up about working as a caregiver in the UK after fame

Sola Sobowale opens up about working as a caregiver in the UK after fame

TikTok & Universal Music Group reaches an agreement to return their songs to the App

TikTok & Universal Music Group reaches an agreement to return their songs to the App

Netflix elevates women filmmakers, diversifies industry representation

Netflix elevates women filmmakers, diversifies industry representation

Mr Macaroni says he's not in the market for a relationship

Mr Macaroni says he's not in the market for a relationship

These are the Nigerian albums released so far in 2024

These are the Nigerian albums released so far in 2024

ADVERTISEMENT
ADVERTISEMENT